SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Nektar Therapeutics (NKTR)

Bad link... try this one for AMLN [#msg-10433899]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SeriousMoney Member Profile
 
Followed By 30
Posts 7,965
Boards Moderated 5
Alias Born 04/05/05
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/17/2017 6:08:01 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/17/2017 6:07:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/17/2017 6:07:06 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/17/2017 6:06:09 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/17/2017 6:05:41 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/17/2017 6:04:46 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/17/2017 6:04:11 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/15/2017 6:04:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2017 7:47:11 AM
First Data for NKTR-214 in Combination with OPDIVO® (nivolumab) for Patients with Stage IV Melanoma, Renal Cell Carcinoma an... "PR Newswire (US)" - 11/11/2017 5:54:00 PM
Nektar to Webcast Presentation at Jefferies 2017 London Healthcare Conference "PR Newswire (US)" - 11/10/2017 8:09:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/8/2017 6:04:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/8/2017 6:03:06 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/8/2017 6:10:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2017 4:52:37 PM
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2017 "PR Newswire (US)" - 11/7/2017 4:10:00 PM
New Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunot... "PR Newswire (US)" - 11/7/2017 8:10:00 AM
Nektar Therapeutics Presents Preclinical Data on NKTR-358, a First-in-Class Regulatory T Cell Stimulator, at 2017 American Co... "PR Newswire (US)" - 11/7/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/3/2017 6:08:44 PM
Nektar to Announce Financial Results for the Third Quarter of 2017 on Tuesday, November 7, 2017, After Close of U.S.-Based Fi... "PR Newswire (US)" - 10/31/2017 6:41:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 6:09:29 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 6:08:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 6:07:40 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 6:08:29 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 6:03:53 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist